论文部分内容阅读
目的探讨在上消化道出血患者中,应用奥美拉唑和凝血酶进行治疗的临床疗效。方法选取我院收治的上消化道出血患者52例进行分析,将其随机分为对照组和观察组,每组26例。对照组采用常规治疗方案,观察组在对照组的基础上加用奥美拉唑和凝血酶。观察两组患者的临床治疗效果,以及不良反应发生情况。结果观察组治疗有效率(96.2%)明显高于对照组(76.9%),患者止血时间短于对照组,差异具有统计学意义(P<0.05)。两组在不良反应发生率上相比差异不大,不具有统计学意义(P>0.05)。结论对于上消化道出血患者而言,应用奥美拉唑和凝血酶进行治疗的临床疗效更佳,显著缩短了患者的止血时间,且不良反应发生较少,是一种安全有效的治疗方法。
Objective To investigate the clinical efficacy of omeprazole and thrombin in patients with upper gastrointestinal hemorrhage. Methods 52 cases of upper gastrointestinal bleeding admitted to our hospital were selected for analysis. They were randomly divided into control group and observation group, with 26 cases in each group. The control group with conventional treatment, the observation group in the control group based on the use of omeprazole and thrombin. The clinical efficacy of the two groups of patients and the incidence of adverse reactions were observed. Results The effective rate (96.2%) in the observation group was significantly higher than that in the control group (76.9%). The bleeding time in the observation group was shorter than that in the control group (P <0.05). There was no significant difference in the incidence of adverse reactions between the two groups, with no statistical significance (P> 0.05). Conclusion For patients with upper gastrointestinal hemorrhage, the application of omeprazole and thrombin in the treatment of clinical efficacy is better, significantly reducing the patient’s bleeding time, and fewer adverse reactions, is a safe and effective treatment.